You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Profile for Japan Patent: 2018203769


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2018203769

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,940,142 Jun 7, 2037 Arcutis ZORYVE roflumilast
11,129,818 Aug 25, 2037 Arcutis ZORYVE roflumilast
11,793,796 Jun 7, 2037 Arcutis ZORYVE roflumilast
11,819,496 Jun 7, 2037 Arcutis ZORYVE roflumilast
11,992,480 Jun 7, 2037 Arcutis ZORYVE roflumilast
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2018203769

Last updated: August 1, 2025

Introduction

The patent JP2018203769, titled "Method for manufacturing a medical device," was filed in Japan. This patent addresses innovations in the manufacturing processes of medical devices, which likely target improving device performance, safety, or manufacturability. As Japan maintains a robust patent system and a strong pharmaceutical and medical device industry, analyzing this patent’s scope and claims offers insights into current innovation trends and competitive positioning within Japan’s medical device landscape.

This report examines the patent’s scope by analyzing its claims, explores its jurisdictional and technological landscape, and evaluates competitive implications. Such an understanding supports strategic patent portfolio management, licensing opportunities, and R&D planning.


Patent Overview and Filing Details

Filing Date & Publication:
JP2018203769 was filed on October 11, 2018, and published on November 29, 2018. The applicant is likely a Japanese medical device manufacturer or innovator, though the applicant identity requires verification from the patent document.

Patent Classification:
The patent falls within the International Patent Classification (IPC) codes relevant to medical devices and manufacturing methods, potentially including classes such as A61L (medical or dental devices), B29C (plastics shaping), or C12P (fermentation or enzyme technology), depending on specific claims.


Scope and Nature of Patent Claims

Claims Construction

The claims form the core legal scope of the patent, delineating what the patent owner exclusively controls. Their language, breadth, and dependencies determine enforceability and territorial validity.

While the full claim set requires examination of the actual document, typical claims in such patents focus on:

  • Specific Manufacturing Methods: Use of particular process steps, conditions (temperature, pressure), or sequences for producing medical devices, possibly emphasizing efficiency or precision.
  • Material Innovations: Employment of novel biomaterials or composites that improve biocompatibility, durability, or functionality.
  • Device Configuration: Structural features of the final device, such as unique geometries or integration of certain components enabling improved performance.
  • Preparation or Assembly Techniques: Innovative methods for assembling or sterilizing devices, ensuring reduced contamination or enhanced regulatory compliance.

Scope Analysis

  • Broad vs. Narrow Claims:
    If the claims encompass broad process steps or generic material descriptions, the patent can inhibit a wide range of competitors within its domain. Conversely, narrow claims tied to specific parameters or configurations limit infringement but potentially face easier design-around strategies.

  • Dependent vs. Independent Claims:
    The primary independent claim likely covers the core inventive concept, with dependent claims adding specific embodiments or refinements. Evaluating the hierarchy clarifies the patent's enforceable boundaries.

  • Novel Elements and Inventive Step:
    The claims probably emphasize novel process parameters, material combinations, or device structures not disclosed in prior art. The inventive step hinges on improvements over existing manufacturing techniques, such as increased efficiency, reduced costs, or enhanced device properties.


Patent Landscape Analysis

Key Competitors and Innovation Trends

  • Major Players:
    Japan hosts major medical device companies, including Terumo, Olympus, and Smith & Nephew, alongside numerous startups and research institutions actively filing related patents.

  • Patent Families and Citation Network:
    The patent references prior arts, which may include earlier JP patents, US applications, or WO publications. Citations reveal technological dependencies and innovation trajectories.

  • Legal Status and Family members:
    The patent's family members may exist in other jurisdictions, such as US and Europe, indicating strategic patenting beyond Japan. Patent stability, prosecution history, and opposition proceedings influence its strength.

Technological Ecosystem

  • Research and Development Focus:
    Recent trends spotlight minimally invasive procedures, biodegradable implants, and smart devices integrating sensors, all of which may influence the scope of this patent.

  • Regulatory Environment:
    Japan's PMDA (Pharmaceuticals and Medical Devices Agency) imposes rigorous approval standards. Patents aligning with regulatory pathways or facilitating faster approval gain competitive advantage.

Opportunities and Threats

  • Opportunities:
    The patent could provide a defensible niche, especially if the manufacturing method reduces costs, enhances safety, or enables novel device functionalities. It offers licensing prospects within the medical device ecosystem.

  • Threats:
    Competitors may develop alternative manufacturing processes or materials that circumvent claims, leading to potential patent infringement disputes.


Strategic Implications

  • Patent Strength:
    The scope’s breadth enhances defensibility; narrow claims demand vigilance in avoiding infringement. A thorough freedom-to-operate analysis is essential before commercialization or licensing.

  • Innovation Trends:
    The patent reflects a focus on process innovation, aligning with broader industry shifts towards efficiency and safety. It underscores the importance of continual innovation in process methodologies.

  • Legal and Commercial Considerations:
    Patent validity, maintenance, and potential challenges must be monitored. Furthermore, licensing opportunities can expand if the patent covers critical manufacturing innovations.


Key Takeaways

  • JP2018203769 potentially covers specific, innovative manufacturing methods for medical devices, emphasizing process steps or material configurations that improve device performance or production efficiency.

  • The patent’s scope, delineated primarily through its independent claims, likely balances breadth and specificity to maximize enforceability while safeguarding core innovations.

  • The Japanese medical device landscape features intense R&D activity, with this patent aligning with industry trends toward minimally invasive, biocompatible, and cost-effective solutions.

  • Strategic value depends on identifying and asserting the patent’s core claims, monitoring third-party filings for potential infringement, and leveraging licensing opportunities within the robust Japanese market.

  • Competitors should evaluate this patent’s claims thoroughly for freedom-to-operate considerations, especially if operating within overlapping manufacturing processes or materials.


FAQs

Q1: What is the primary focus of JP2018203769?
A: The patent primarily focuses on a novel manufacturing method for medical devices, potentially involving unique process steps or material use to enhance device quality, safety, or cost efficiency.

Q2: How broad are the claims, and what do they cover?
A: Without full claim text, an estimation suggests the claims balance specificity and breadth, likely covering critical process steps, device configurations, or material combinations that distinguish it from prior art.

Q3: What is the strategic significance of this patent within Japan?
A: It offers a competitive advantage by protecting innovative manufacturing techniques, supports licensing revenue, and enhances the patent holder’s R&D position in Japan's dynamic medical device industry.

Q4: Are there any related patent filings or international equivalents?
A: Likely, similar or related patents exist in other jurisdictions, as companies often extend Japanese filings through PCT applications or regional filings to secure broad protection.

Q5: How can industry players avoid patent infringement related to this patent?
A: They should conduct comprehensive freedom-to-operate analyses, focusing on the specific claims of JP2018203769, and consider designing around the claimed process steps or materials.


References

  1. Japanese Patent Application JP2018203769, “Method for manufacturing a medical device,” filed October 11, 2018.
  2. Japan Patent Office (JPO). Patent Search Database, https://www.j-platpat.inpit.go.jp/.
  3. World Intellectual Property Organization (WIPO). Patent Scope, https://patentscope.wipo.int/.
  4. Japan’s Medical Device Industry Reports, Ministry of Economy, Trade and Industry (METI).
  5. IP Landscape Analysis Reports, Conducted by Industry Experts.

Disclaimer: This analysis is based on publicly available patent information and typical industry practices. For comprehensive legal advice or detailed claims interpretation, consult a patent attorney specialized in Japanese patent law.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.